特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
944035

副鼻腔炎治療薬の臨床試験:2020上半期

Sinusitis Global Clinical Trials Review, H1, 2020

出版日: | 発行: GlobalData | ページ情報: 英文 563 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.84円
副鼻腔炎治療薬の臨床試験:2020上半期
出版日: 2020年05月04日
発行: GlobalData
ページ情報: 英文 563 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、2020年上半期に世界各地で行われている副鼻腔炎治療薬の臨床試験について調査したもので、主要国で行われている臨床試験の件数と平均登録数、治験の段階、エンドポイントの状況、治験依頼者などを国別(G7とE7)、地域別にまとめています。

レポートの概要

  • 世界の臨床試験の状況についてのスナップショット
  • 地域別、国(G7とE7)別、治験の進捗状況、治験の段階、治験依頼者、エンドポイント状況別の臨床試験に関連するトップレベルのデータ
  • 主要企業に関連するすべての治験(治験のタイトル、段階、進捗状況)の情報
  • 完了していない治験(終了、中断、中止)とその理由
  • 過去5年間の登録の傾向
  • 過去3ヶ月間の最新のニュース

目次

レポートのガイダンス

調査範囲

各地域で行われている臨床試験

  • 国別の臨床試験と平均登録数
  • アジア太平洋で臨床試験の件数が多い国上位5ヶ国
  • 欧州で臨床試験の件数が多い国上位5ヶ国
  • 北米で臨床試験の件数が多い国
  • 中東・アフリカで臨床試験の件数が多い国上位5ヶ国
  • 南米で臨床試験の件数が多い国上位5ヶ国

G7諸国での臨床試験:耳鼻咽喉疾患治療薬の治験のなかで副鼻腔炎治療薬が占める割合

G7諸国での段階別の臨床試験

G7諸国での治験進捗状況別の臨床試験

E7諸国での別臨床試験:耳鼻咽喉疾患治療薬の治験のなかで副鼻腔炎治療薬が占める割合

E7諸国での段階別の臨床試験

のE7諸国での治験進捗状況別の臨床試験

段階別の臨床試験

  • 各段階で進行中の試験

治験進捗状況別の治験

エンドポイント状況別の臨床試験

一定期間行われた被験者募集

治験依頼者タイプ別の臨床試験

主な治験依頼者

  • 副鼻腔炎の治療薬の臨床試験に参加している主な企業

主な医薬品

臨床試験プロファイルのスナップショット

付録

  • 略語
  • 定義
  • 調査手法
  • 2次調査
  • GlobalDataについて
  • お問い合わせ
  • 資料
図表

List of Tables

List of Tables

  • Sinusitis Therapeutics, Global, Clinical Trials by Region, 2020*
  • Sinusitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Sinusitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 20

List of Figures

List of Figures

  • Sinusitis Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Sinusitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Sinusitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Sinusitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Sinusitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Sinusitis Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Sinusitis Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020*
  • Sinusitis Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020*
  • Proportion of Sinusitis to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2020*
  • Sinusitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Sinusitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Sinusitis to Ear Nose Throat Disorders Clinical Trials, E7 Countries (%), 2020*
  • Sinusitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Sinusitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Sinusitis Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Sinusitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Sinusitis Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Sinusitis Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Sinusitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Sinusitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Sinusitis Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Sinusitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Sinusitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • GlobalData Methodology
目次
Product Code: GDHC6206CTIDB

GlobalData's clinical trial report, "Sinusitis Global Clinical Trials Review, H1, 2020" provides an overview of Sinusitis Clinical trials scenario. This report provides top line data relating to the clinical trials on Sinusitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Report Guidance

GlobalData Clinical Trials Report Coverage

Clinical Trials by Region

  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Sinusitis to Ear Nose Throat Disorders Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Sinusitis to Ear Nose Throat Disorders Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

  • In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

  • Top Companies Participating in Sinusitis Therapeutics Clinical Trials

Prominent Drugs

Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.